Unexpectedly, RanBP17 protein expression was markedly induced after AG1478 treatment in the two tested HNSCC cell lines UM-SCC-3 and UT-SCC-26A, with a concomitant expected reduction of PCNA levels (Fig. 5A). The gene discussed is RANBP17; the disease is head and neck squamous cell carcinoma.